课题基金 / 基金详情

Development of an ICMT Supported Membrane Sensor

Development of an ICMT Supported Membrane Sensor
ICMT 支持的薄膜传感器的开发
批准号:
7560063
负责人:
DAVID H THOMPSON
金额:
$38.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2012-01-31
关键词:
Active Biological TransportAddressAdenosylhomocysteinaseAdsorptionAffinityAmino Acid MotifsAmino AcidsAnalytical ChemistryAntibodiesArchitectureAreaBindingBiochemical ReactionBiochemistryBiologicalBiological AssayBiological ModelsC-terminalCell membraneCellsChemotherapy-Oncologic ProcedureChimeric ProteinsComputer Systems DevelopmentConfocal MicroscopyCoupledCysteineDataDepositionDetectionDevelopmentDevicesDiffusionDilution TechniquesDimensionsDiseaseDisulfidesElementsEndoplasmic ReticulumEngineeringEnzymesEpitopesEquilibriumEventExposure toFamilyFilmFlowchartsFluorescenceFluorescence Recovery After PhotobleachingFutureGenerationsGoalsGreen Fluorescent ProteinsHemagglutininHistidineHomocysteineHomocystineHydrolaseHydrolysisImmunofluorescence ImmunologicIntegral Membrane ProteinInterference MicroscopyInterventionIonic StrengthsLateralLeadLibrariesLinkLipidsLiposomesMaintenanceMattressesMeasuresMechanicsMediatingMembraneMembrane ProteinsMethodsMethylationMicellesMissionModelingMolecularMolecular ConformationMolecular WeightMonitorMonte Carlo MethodNitrilotriacetic AcidNutrientOncogenicOperative Surgical ProceduresOutcomePerformancePharmaceutical PreparationsPhasePlayPolyethylene GlycolsPolyethylenesPost-Translational Protein ProcessingPreclinical Drug EvaluationPrincipal InvestigatorProductionPropertyProteinsReactionRefractoryReporterResearchResearch PersonnelRoleSaccharomyces cerevisiaeSchemeSideSignal TransductionSilicon DioxideSolidSolutionsStructureSubarachnoid HemorrhageSulfhydryl CompoundsSurfaceSystemTechniquesTechnologyTemperatureTestingTherapeutic AgentsThickTimeValidationVariantVesiclebasecell transformationchemotherapeutic agentdensitydesigndetectordrug candidatedrug developmentdrug discoveryextracellularfluorophorefunctional grouphigh throughput screeningimprovedinhibitor/antagonistinnovationisoprenylcysteine carboxylmethyltransferasemembermilligrammultidisciplinarynovelnovel strategiesnovel therapeuticspathogenpreventprogramsprotein expressionprotein functionras Proteinsreceptorreconstitutionresearch studyresponsesensortheoriestooltumorvapor

项目摘要

项目成果

DAVID H THOMPSON的其他基金

相似基金

相关文献

中文摘要
翻译
该项目的长期目标是开发基于薄膜的多元件传感器阵列
英文摘要
The long term goal of this project is the development of multi-element membrane-based sensor arrays on a single chip for high-throughput, parallel sensing of therapeutic agent candidates acting on specific membrane protein targets. Successful development of this sensing technology can lead to accelerated drug discovery targeted to membrane proteins involved in a variety of diseases. We will develop a stabilized asymmetric membrane structure containing isoprenylcysteine carboxylmethyltransferase (ICMT) in this project as a potential new tool for drug discovery in cancer chemotherapy. ICMT is a membrane protein in the endoplasmic reticulum responsible for the carboxylmethylation of -CaaX motif proteins, including the Ras signal transduction proteins. This membrane sensor architecture will enable the detection of Icmt-mediated methylation of the model substrate N-acetylfarnesylcysteine as a change in fluorescence emission due to the coupled cleavage of a disulfide-linked molecular beacon. Sensors developed from these asymmetric structures will provide a direct indication of a drug candidate's ability to inhibit methylation catalyzed by Icmt. This approach will serve as a powerful tool for screening drug libraries for lead compounds that are likely to inhibit the methylation of cellular oncogenic Ras proteins. Discovery and development of these compounds are important because inhibition of Ras carboxylmethylation promotes not only the mislocalization of the Ras proteins, but also inhibits the ability of Ras to transform cells. ICMT is an excellent model system for development of this membrane-based sensor because many well-characterized substrates exist to provide data validation. These substrates will be used as tools to develop a high-throughput screening approach that may lead to improved chemotherapeutic agents for refractory tumors. Subsequent phases of the project will address the design, fabrication, characterization, and validation of multi-element sensor arrays on an optically transparent substrate. A multidisciplinary team approach will be used, combining expertise in biochemistry, materials synthesis and characterization, analytical chemistry, and theory to achieve the target supported membrane device. Future extension of this detector array concept could have far reaching potential for accelerating the discovery of new therapeutic agents targeted to many other classes of membrane-associated proteins.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/bc050027d
发表时间: 2005-04
期刊: Bioconjugate chemistry
影响因子: 4.7
作者: [Heather B Hodges;Mingkang Zhou;S. Haldar;Jessica L Anderson;D. Thompson;C. Hrycyna]
通讯作者: Heather B Hodges;Mingkang Zhou;S. Haldar;Jessica L Anderson;D. Thompson;C. Hrycyna
DOI: 10.1529/biophysj.106.102764
发表时间: 2007-10
期刊: Biophysical journal
影响因子: 3.4
作者: [G. Longo;D. Thompson;I. Szleifer]
通讯作者: G. Longo;D. Thompson;I. Szleifer
DOI: 10.1021/la901735d
发表时间: 2009-10-20
期刊: Langmuir : the ACS journal of surfaces and colloids
影响因子: --
作者: [Ren CL, Carvajal D, Shull KR, Szleifer I]
通讯作者: Szleifer I
DOI: 10.1021/jp8080904
发表时间: 2008-12-18
期刊: The journal of physical chemistry. B
影响因子: --
作者: [Ren CL, Nap RJ, Szleifer I]
通讯作者: Szleifer I
Development of Long-circulating, Degradable Gd-Polyrotaxane MR Agents
  • 批准号:
    8824207
  • 项目类别:
  • 资助金额:
    $20.35万
  • 财政年份:
    2014
  • 负责人:
    DAVID H THOMPSON
  • 依托单位:
Development of Long-circulating, Degradable Gd-Polyrotaxane MR Agents
  • 批准号:
    8935773
  • 项目类别:
  • 资助金额:
    $22.84万
  • 财政年份:
    2014
  • 负责人:
    DAVID H THOMPSON
  • 依托单位:
Development of Bioresponsive Lipids for Intracellular Delivery
  • 批准号:
    8018991
  • 项目类别:
  • 资助金额:
    $29.03万
  • 财政年份:
    2009
  • 负责人:
    DAVID H THOMPSON
  • 依托单位:
Development of Bioresponsive Lipids for Intracellular Delivery
  • 批准号:
    8214528
  • 项目类别:
  • 资助金额:
    $28.99万
  • 财政年份:
    2009
  • 负责人:
    DAVID H THOMPSON
  • 依托单位:
海外基金